126 results
Page 4 of 7
424B5
s8jlvc918fytl0j
10 May 19
Prospectus supplement for primary offering
4:16pm
8-K
EX-99.1
18kptmgo0ow279e1
9 May 19
Results of Operations and Financial Condition
7:10am
PRE 14A
qnadf5 3z
2 Apr 19
Preliminary proxy
4:29pm
POS AM
8qnjo345ksp 3z
28 Feb 19
Prospectus update (post-effective amendment)
4:54pm
POSASR
vzpggj jlvd8jk1fmw
28 Feb 19
Automatic shelf registration (post-effective amendment)
4:17pm
8-K
EX-99.1
6k08evxqt 0dz6jlewni
28 Feb 19
Karyopharm Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update
7:22am
8-K
EX-99.1
7ic r8qqja6jy
8 Nov 18
Karyopharm Reports Third Quarter 2018 Financial Results and Highlights Recent Company Progress
7:08am
424B5
jhdz0a9 gg2rz4ciw2m
17 Aug 18
Prospectus supplement for primary offering
4:05pm
8-K
EX-99.1
sut3rk
7 Aug 18
Karyopharm Reports Second Quarter 2018 Financial Results and Highlights Recent Progress
7:18am
S-3ASR
afs xvbr8kc
2 Jul 18
Automatic shelf registration
4:08pm
8-K
EX-99.1
jy65 mjagja
20 Jun 18
Regulation FD Disclosure
7:01am
8-K
EX-99.1
zxd3zyzzn3 95sr
7 Jun 18
Regulation FD Disclosure
7:00am
8-K
EX-99.1
6vbkj3 wbf14
24 May 18
Entry into a Material Definitive Agreement
7:10am
8-K
EX-99.1
kb8au2s
10 May 18
Karyopharm Reports First Quarter 2018 Financial Results and Highlights Recent Progress
7:11am